Your Search Results

Over 1,000 patients enrolled in landmark SELUTION DeNovo study

14 Mar 2023

MedAlliance’s SELUTION SLR™ drug-eluting balloon (DEB) receives FDA Investigational Device Exemption (IDE) approval, making it the first limus DEB to be available to US patients

26 May 2022

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

09 Aug 2022

In remembrance of Alain Cribier

17 Feb 2024

It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...

Coronary bifurcation lesions

08 Jul 2025

This updated chapter by T. Lefèvre provides a practical guide on strategies currently implemented in the treatment of coronary bifurcations, and highlights the main challenges and most debated issues to propose recommendations for an optimal approach.

Authors :

Lefèvre T., Hovasse T.

The PCR Textbook chapter on Bifurcation lesions

CATHI Launches First New Generation Right Heart Catheter Simulator

09 Mar 2022

egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the United States

04 Apr 2022

Bentley launches the BeBack crossing catheter

26 Jan 2023

First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing

14 Jun 2024

This EIJ image highlights a new device designed to enhance the safety and efficiency of ViV TAVI procedures, particularly TAV-in-TAV, by reducing attempts to cross the valve and preventing guidewire misnavigation, thereby minimizing complications and procedure time.

First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

12 Jan 2022

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

29 Jul 2022

MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study

25 Jan 2023

MedAlliance acquired by Cordis for up to USD 1.135 billion

02 Oct 2023

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...